Untargeted Metabolomic Profiling Reveals Lipid Metabolism Dysregulation in Patients With Immune Thrombocytopenia
Scandinavian Journal of Immunology · 2025-12 · 102 (6)
DOI: 10.1111/sji.70077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, online erschienen am 11.12.2025. Verfasst von Xin Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Metabolomics, Lipid Metabolism. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Immune thrombocytopenia (ITP) is an acquired autoimmune disorder characterised by immune‐mediated platelet destruction, yet its metabolic underpinnings remain incompletely understood. In this study, we applied a non‐targeted serum metabolomics approach to characterise metabolic alterations in ITP and to explore candidate diagnostic biomarkers. A total of 37 serum samples were collected, including 20 from patients with ITP and 17 from age‐ and sex‐matched healthy individuals. Global metabolite profiling was performed, followed by quantitative analyses, identification of differentially expressed metabolites, and functional annotation. Machine learning algorithms were then used to construct a diagnostic prediction model based on differential metabolites. Compared with healthy controls, ITP patients exhibited a distinct metabolic signature dominated by alterations in lipids and lipid‐like molecules, with 680 metabolites upregulated and 589 downregulated. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis revealed prominent involvement of lipid metabolism, cholesterol metabolism, and unsaturated fatty acid metabolism pathways. Among the differential metabolites, isopimpinellin and oleic acid emerged as highly characteristic of ITP. The prediction model built on these metabolomic features achieved a sensitivity of 78%, a specificity of 100%, and an area under the receiver operating characteristic curve of 0.83, indicating promising diagnostic performance. These findings suggest that dysregulated lipid metabolism is a central feature of ITP and support the potential of serum metabolomics‐based machine learning models to aid in the identification of novel biomarkers and to improve early diagnosis of this immune‐mediated thrombocytopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Department of Cardiology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China.
- Department of Hematology, The Second Hospital of Shandong University, Jinan, Shandong, China.
ORCID-Profile: Xin Zhou, Ningning Shan
Zitieren
APA
Zhou, X., Shi, Y., Li, M., Song, J., & Shan, N. (2025). Untargeted Metabolomic Profiling Reveals Lipid Metabolism Dysregulation in Patients With Immune Thrombocytopenia. Scandinavian Journal of Immunology, 102(6). https://doi.org/10.1111/sji.70077
Vancouver
Zhou X, Shi Y, Li M, Song J, Shan N. Untargeted Metabolomic Profiling Reveals Lipid Metabolism Dysregulation in Patients With Immune Thrombocytopenia. Scandinavian Journal of Immunology. 2025;102(6). doi:10.1111/sji.70077
BibTeX
@article{Zhou2025,
author = {Zhou, Xin and Shi, Yuqi and Li, Mengran and Song, Jiarui and Shan, Ningning},
title = {Untargeted Metabolomic Profiling Reveals Lipid Metabolism Dysregulation in Patients With Immune Thrombocytopenia},
journal = {Scandinavian Journal of Immunology},
year = {2025},
volume = {102},
number = {6},
doi = {10.1111/sji.70077}
}
EUVIMED